243
Views
19
CrossRef citations to date
0
Altmetric
OBSTETRICS

Angiogenic growth factors in maternal and fetal serum in pregnancies complicated with intrauterine growth restriction

, , &

References

  • Figueras F, Gardosi J. 2011. Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. American Journal of Obstetrics and Gynecology 204:288–300.
  • Gourvas V, Dalpa E, Konstantinidou A, Vrachnis N, Spandidos DA, Sifakis S. 2012. Angiogenic factors in placentas from pregnancies complicated by fetal growth restriction. Molecular Medicine Reports 6:23–27.
  • Jacobs M, Nassar N, Roberts CL, Hadfield R, Morris JM, Ashton AW. 2011. Levels of soluble fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review. Reproductive Biology and Endocrinology 9:77.
  • Kendall RL, Thomas KA. 1993. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proceedings of the National Academy of Sciences of the United States of America 90:10705–10709.
  • Maulik D, Frances Evans J, Ragolia L. 2006. Fetal growth restriction: pathogenic mechanisms. Clinical Obstetrics and Gynecology 49:219–227.
  • Savvidou MD, Yu CK, Harland LC, Hingorani AD, Nicolaides KH. 2006. Maternal serum concentration of soluble fms-like tyrosine kinase 1 and vascular endothelial growth factor in women with abnormal uterine artery Doppler and in those with fetal growth restriction. American Journal of Obstetrics and Gynecology 195:1668–1673.
  • Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW et al. 2007. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clinical Science 112:51–57.
  • Wathen KA, Tuutti E, Stenman UH, Alfthan H, Halmesmaki E, Finne P et al. 2006. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation. Journal of Clinical Endocrinology and Metabolism 91:180–184.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.